Vitamin E and all-cause mortality: a meta-analysis
- PMID: 21235492
- PMCID: PMC4030744
- DOI: 10.2174/1874609811104020158
Vitamin E and all-cause mortality: a meta-analysis
Abstract
The current analysis reexamines the relationship between supplemental vitamin E and all-cause mortality. All randomized, controlled trials testing the treatment effect of vitamin E supplementation in adults for at least one year were sought. MEDLINE, the Cochrane Library, and Biological Abstracts databases were searched using the terms "vitamin E," "alpha-tocopherol," "antioxidants," "clinical trial," and "controlled trial" for studies published through April 2010; results were limited to English, German, or Spanish language articles. Studies were also obtained through reference mining. All randomized controlled trials using vitamin E, with a supplementation period of at least one year, to prevent or treat disease in adults were identified and abstracted independently by two raters. Mortality data from trials with a supplementation period of at least one year were pooled. The selected trials (n = 57) were published between 1988 and 2009. Sample sizes range from 28 to 39,876 (median = 423), yielding 246,371 subjects and 29,295 all-cause deaths. Duration of supplementation for the 57 trials range from one to 10.1 years (median = 2.6 years). A random effects meta-analysis produce an overall risk ratio of 1.00 (95% confidence interval: 0.98, 1.02); additional analyses suggest no relationship between dose and risk of mortality. Based on the present meta-analysis, supplementation with vitamin E appears to have no effect on all-cause mortality at doses up to 5,500 IU/d.
Figures
Similar articles
-
Vitamin E for Alzheimer's dementia and mild cognitive impairment.Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5. Cochrane Database Syst Rev. 2017. PMID: 28418065 Free PMC article. Review.
-
Antioxidant supplementation for lung disease in cystic fibrosis.Cochrane Database Syst Rev. 2014 Aug 7;(8):CD007020. doi: 10.1002/14651858.CD007020.pub3. Cochrane Database Syst Rev. 2014. PMID: 25102015 Review.
-
Vitamin D supplementation for prevention of mortality in adults.Cochrane Database Syst Rev. 2014 Jan 10;(1):CD007470. doi: 10.1002/14651858.CD007470.pub3. Cochrane Database Syst Rev. 2014. PMID: 24414552 Review.
-
Vitamin C and vitamin E for Alzheimer's disease.Ann Pharmacother. 2005 Dec;39(12):2073-80. doi: 10.1345/aph.1E495. Epub 2005 Oct 14. Ann Pharmacother. 2005. PMID: 16227450 Review.
-
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.Ann Intern Med. 2005 Jan 4;142(1):37-46. doi: 10.7326/0003-4819-142-1-200501040-00110. Epub 2004 Nov 10. Ann Intern Med. 2005. PMID: 15537682
Cited by
-
Oxidative Stress in Military Missions-Impact and Management Strategies: A Narrative Analysis.Life (Basel). 2024 Apr 27;14(5):567. doi: 10.3390/life14050567. Life (Basel). 2024. PMID: 38792589 Free PMC article. Review.
-
Hypogonadism and nonalcoholic fatty liver disease.Endocrine. 2024 May 21. doi: 10.1007/s12020-024-03878-1. Online ahead of print. Endocrine. 2024. PMID: 38771482 Review.
-
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?Endocrine. 2024 Mar 22. doi: 10.1007/s12020-024-03783-7. Online ahead of print. Endocrine. 2024. PMID: 38519764 Review.
-
The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis.Nutrients. 2023 Aug 25;15(17):3733. doi: 10.3390/nu15173733. Nutrients. 2023. PMID: 37686767 Free PMC article. Review.
-
Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes.World J Hepatol. 2023 Apr 27;15(4):477-496. doi: 10.4254/wjh.v15.i4.477. World J Hepatol. 2023. PMID: 37206648 Free PMC article. Review.
References
-
- Institute of Medicine. A report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food Nutrition Board. Washington, DC: National Academies Pr; 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids.
-
- Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz G, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. NEJM. 1993;328:1450–6. - PubMed
-
- Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. NEJM. 1993;328:1444–9. - PubMed
-
- Hayden KM, Welsh-Bohmer KA, Wengreen HJ, Zandi PP, Lyketsos CG, Breitner JCS. Risk of mortality with vitamin E supplements: The Cache County Study. Am J Med. 2007;120:180–4. - PubMed
-
- Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356:1213–18. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous